Research
Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograft
-
* Corresponding author: Qiang Wu aydjohn@yahoo.com
- † Equal contributors
Journal of Ovarian Research 2010, 3:20 doi:10.1186/1757-2215-3-20
No comments have yet been made on this article.